Bluebird bio reports inducement grants under nasdaq listing rule 5635(c)(4)

Somerville, mass.--(business wire)--bluebird bio, inc. (nasdaq: blue) today announced that the compensation committee of the company's board of directors approved the grant of inducement awards of 242,500 restricted stock units (rsus). this includes the previously disclosed 100,000 rsus granted to the company's cfo, james sterling, with a grant date of september 30, 2024 and 142,500 rsus granted to 19 other employees, with a grant date of october 1, 2024 (collectively, the “inducement grants”).
NDAQ Ratings Summary
NDAQ Quant Ranking